Fresenius Medical Care AG FMCQF
Annual
Quarterly
FY2013 · ended Dec 31, 2013 · Revenue $4.97B · Filed Feb 25, 2014
Fresenius Medical Care AG (FMS) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In fiscal 2013, which ended Dec 31, 2013, it reported revenue of $5.0 billion and net income of $1.1 billion. Free cash flow was $1.3 billion. As of Dec 31, 2013 it held $682.8 million in cash and investments and $7.8 billion in total debt.
Revenue
$4.97B
Net income
$1.11B
-6.5% vs prior year
Operating cash flow
$2.03B
-0.2% vs prior year
Free cash flow
$1.29B
-5.6% vs prior year
EPS
$3.65
+4.0% vs prior year
Dividend per share
None
Shares outstanding
279.29M
-4.8% vs prior year
Net cash
$-7.16B
FY 2013
Operating margin
45.4%
FY 2013
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- FMS (NYSE), FMCQF (OTC)
- Headquarters
- Bad Homburg, Germany
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1333141
- Former names
- Fresenius Medical Care AG & Co. KGaA (until Nov 21, 2023)
Other Services-Misc Health & Allied Services, NEC companies
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2013 Dec 31, 2013 |
FY 2012 Dec 31, 2012 |
FY 2011 Dec 31, 2011 |
FY 2010 Dec 31, 2010 |
FY 2009 Dec 31, 2009 |
|---|---|---|---|---|---|
| Revenue | $5.0B | — | — | — | — |
| Operating income | $2.3B | $2.2B | $2.1B | $1.9B | $1.8B |
| Net income | $1.1B | $1.2B | $1.1B | $978.5M | $891.1M |
| Diluted EPS | $3.65 | — | $3.51 | $3.24 | $2.99 |
| Operating cash flow | $2.0B | $2.0B | $1.4B | $1.4B | $1.3B |
| Free cash flow | $1.3B | $1.4B | $848.6M | $844.5M | $765.0M |
| Total assets | $23.1B | $22.3B | $19.5B | $17.1B | $15.8B |
| Total liabilities | $13.0B | $12.6B | $11.1B | $9.3B | $8.8B |
| Stockholders' equity | $9.2B | $8.9B | $7.9B | $7.4B | $6.7B |
| Cash and investments | $682.8M | $688.0M | $457.3M | $522.9M | $301.2M |
| Total debt | $7.8B | $7.9B | $5.6B | $4.7B | $316.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Oct 7, 2026 | Oct 7, 2026 |
| 6-K | Current report (foreign issuer) | Sep 25, 2026 | Sep 25, 2026 |
| 6-K | Current report (foreign issuer) | Aug 27, 2026 | Aug 27, 2026 |
| 6-K | Current report (foreign issuer) | Aug 4, 2026 | Jun 30, 2026 |
All 600 Fresenius Medical Care AG SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.